MDCalc

MuLBSTA Score for Viral Pneumonia Mortality

Predicts 90-day mortality in patients with viral pneumonia.

Launched during COVID-19 crisis. Not externally validated. Use with caution.

Tips for COVID-19: Use after diagnosis to determine dispo. Specific for Viral PNA and similar inputs as known COVID-19 mortality risk factors, but not externally validated.

Multilobe infiltrate

Absolute Lymphocyte count ≤0.8 x 109/L

Bacterial coinfection

Detected by sputum or blood culture

Smoking history

History of hyper-Tension

Age ≥60 years

Result:

Please fill out required fields.
Advice

  • Threshold for disposition may change during resource-limited situations such as the current COVID-19 outbreak. 

  • Take into consideration that the upper limit of the “low risk” group as indicated in the original study still carries a relatively high mortality rate (e.g. 11 points = 12.27% mortality).

Critical Actions

If applying to a patient with potential COVID-19, use this score in conjunction with clinical suspicion and risk factors - particularly advanced age and comorbidities.